Director, National Institute of Diabetes and Digestive and Kidney Diseases
Chief, Molecular and Clinical Hematology Branch (NIDDK)
Section Chief, Molecular Hematology Section (NIDDK)
National Institutes of Health
Dr. Griffin P. Rodgers, MD, MACP, was named director of the National Institute of Diabetes and Digestive and Kidney Diseases – part of the National Institutes of Health – in 2007. He provides scientific leadership and manages a staff of more than 600 employees and a budget of $2.0 billion.
Dr. Rodgers is widely recognized for his contributions to the development of the first effective, and now FDA-approved, therapy for sickle cell anemia. Recently, he and his collaborators reported on a modified blood stem-cell transplant regimen that is highly effective in reversing sickle cell disease in adults and is associated with relatively low toxicity. He has been honored for his research with numerous awards including the Legacy of Leadership Award in 2002 and a Mastership from the American College of Physicians in 2005. He was also named a finalist in the 2015 Samuel J. Heyman Service to America Medals.
Dr. Rodgers has been an invited professor at medical schools and hospitals both nationally and internationally. He is a member of the American Society of Hematology, the American Academy of Arts and Sciences, and the Institute of Medicine of the National Academy of Science, among others. He has published more than 200 original research articles, reviews and book chapters, has edited four books and monographs, and holds three patents.